DTC ad oversight by FDA should include corrective ad campaigns, consumer rep suggests.
This article was originally published in The Tan Sheet
Executive Summary
DTC AD OVERSIGHT OF CORRECTIVE CAMPAIGNS SUGGESTED BY CONSUMER REP on the basis that FDA's current program does not ensure patients receive balanced information if a campaign is found to be misleading, National Women's Health Network Exec Director Cynthia Pearson told an agency "stakeholders" meeting Aug. 17. "If the FDA directs companies to revise an ad campaign or orders the ad pulled, consumers have no way of knowing that. An entire nation of magazine readers and TV viewers have seen the ad and the damage has already been done," Pearson asserted.